Mycobacterium enoyl acyl carrier protein reductase (InhA): A key target for antitubercular drug discovery

MS Prasad, RP Bhole, PB Khedekar, RV Chikhale - Bioorganic Chemistry, 2021 - Elsevier
MS Prasad, RP Bhole, PB Khedekar, RV Chikhale
Bioorganic Chemistry, 2021Elsevier
Enoyl acyl carrier protein reductase (InhA) is a key enzyme involved in fatty acid synthesis
mainly mycolic acid biosynthesis that is a part of NADH dependent acyl carrier protein
reductase family. The aim of the present literature is to underline the different scaffolds or
enzyme inhibitors that inhibit mycolic acid biosynthesis mainly cell wall synthesis by
inhibiting enzyme InhA. Various scaffolds were identified based on the screening
technologies like high throughput screening, encoded library technology, fragment-based …
Abstract
Enoyl acyl carrier protein reductase (InhA) is a key enzyme involved in fatty acid synthesis mainly mycolic acid biosynthesis that is a part of NADH dependent acyl carrier protein reductase family. The aim of the present literature is to underline the different scaffolds or enzyme inhibitors that inhibit mycolic acid biosynthesis mainly cell wall synthesis by inhibiting enzyme InhA. Various scaffolds were identified based on the screening technologies like high throughput screening, encoded library technology, fragment-based screening. The compounds studied include indirect inhibitors (Isoniazid, Ethionamide, Prothionamide) and direct inhibitors (Triclosan/Diphenyl ethers, Pyrrolidine Carboxamides, Pyrroles, Acetamides, Thiadiazoles, Triazoles) with better efficacy against drug resistance. Out of the several scaffolds studied, pyrrolidine carboxamides were found to be the best molecules targeting InhA having good bioavailability properties and better MIC. This review provides with a detailed information, analysis, structure activity relationship and useful insight on various scaffolds as InhA inhibitors.
Elsevier
以上显示的是最相近的搜索结果。 查看全部搜索结果